In Case You Missed It
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Analysts blame drug companies, not pharmacy benefit managers, for the rising cost of drugs.
The rapidly growing genetic testing concern is executing its growth plan marvelously.
Here are Wednesday's top research calls, including upgrades for Best Buy, Marathon Petroleum and 3M, and downgrades for Humana and Kellogg.
The powerful rally off the November lows has pushed UnitedHealth into extremely overbought territory.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.